Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties.
Jung AC, Ray AM, Ramolu L, Macabre C, Simon F, Noulet F, Blandin AF, Renner G, Lehmann M, Choulier L, Kessler H, Abecassis J, Dontenwill M, Martin S. Jung AC, et al. Among authors: renner g. Oncotarget. 2015 Dec 8;6(39):41884-901. doi: 10.18632/oncotarget.6099. Oncotarget. 2015. PMID: 26474461 Free PMC article.
Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.
Renner G, Janouskova H, Noulet F, Koenig V, Guerin E, Bär S, Nuesch J, Rechenmacher F, Neubauer S, Kessler H, Blandin AF, Choulier L, Etienne-Selloum N, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M. Renner G, et al. Cell Death Differ. 2016 Apr;23(4):640-53. doi: 10.1038/cdd.2015.131. Epub 2015 Oct 16. Cell Death Differ. 2016. PMID: 26470725 Free PMC article.
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.
Blandin AF, Renner G, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M. Blandin AF, et al. Among authors: renner g. Front Pharmacol. 2015 Nov 24;6:279. doi: 10.3389/fphar.2015.00279. eCollection 2015. Front Pharmacol. 2015. PMID: 26635609 Free PMC article. Review.
Wie bewährt sich die Kaufman Assessment Battery for Children-II in der klinischen Anwendungspraxis? Befunde bei 7- bis 12-jährigen Kindern / How Does the Kaufman Assessment Battery for Children-II Stand the Test of Clinical Practice? Findings in 7- To 12-Year-Old Children.
Renner G, Schroeder A, Irblich D. Renner G, et al. Prax Kinderpsychol Kinderpsychiatr. 2024 Mar;73(3):253-274. doi: 10.13109/prkk.2024.73.3.253. Prax Kinderpsychol Kinderpsychiatr. 2024. PMID: 38634389 German.
134 results